Custom Premix Selecting "Custom Premix" option means that all of the beads you have chosen will be premixed in manufacturing before the kit is sent to you.
Catalogue Number
Ordering Description
Qty/Pack
List
この品目はお気に入りに追加されました。
動物種
パネルタイプ
選択したキット
数量
カタログ番号
注文内容
Qty/Pk
価格
96-Well Plate
数量
カタログ番号
注文内容
Qty/Pk
価格
その他の試薬を追加 （MAPmatesとともに使用するにはバッファーおよび検出キットが必要です）
数量
カタログ番号
注文内容
Qty/Pk
価格
48-602MAG
Buffer Detection Kit for Magnetic Beads
1 Kit
Space Saver Option（チェックを入れると箱詰めから袋詰めに変更となりますのでご注意ください） Customers purchasing multiple kits may choose to save storage space by eliminating the kit packaging and receiving their multiplex assay components in plastic bags for more compact storage.
A competitive blocker of benzodiazepine activation of inhibitory GABAergic synpases (ID50 = 200 µg/kg/i.p). Binds to the benzodiazepine site of GABAA receptors. Enhances GABAA-receptor mediated currents and antagonizes the enhancing effects of benzodiapine agonist flurazepam. Exhibits fast association and dissociation from the benzodiazepine binding site. Permeates the blood brain barrier, however, the level of uptake may depend on efflux effects of p-glycogprotein transporter.
Catalogue Number
505991
Brand Family
Calbiochem®
Synonyms
GABAA Receptor Antagonist, Flumazenil, Ro 15-1788
References
References
Froklage, F.E., et al. 2012. EJNMMI Research.2, 12. Li, J., et al. 2006. Neuropharmacol.51, 168. Weiss, M., et al. 2002. Neurochem. Res.27, 1605. Atack, J., et al. 1999. Neuropsychopharmacol.20, 255. Votey, S.R., et al. 1991. Ann. Emerg. Med.20, 181.
Froklage, F.E., et al. 2012. EJNMMI Research.2, 12. Li, J., et al. 2006. Neuropharmacol.51, 168. Weiss, M., et al. 2002. Neurochem. Res.27, 1605. Atack, J., et al. 1999. Neuropsychopharmacol.20, 255. Votey, S.R., et al. 1991. Ann. Emerg. Med.20, 181.
データシート
Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.
Revision
12-September-2013 JSW
Synonyms
GABAA Receptor Antagonist, Flumazenil, Ro 15-1788
Description
A competitive blocker of benzodiazepine activation of inhibitory GABAergic synpases (ID50 = 200 mg/kg/i.p). Binds to the benzodiazepine site of GABAA receptors. Enhances GABAA-receptor mediated currents and antagonizes the enhancing effects of benzodiapine agonist flurazepam. Exhibits fast association and dissociation from the benzodiazepine binding site. Permeates the blood brain barrier, however, the level of uptake may depend on efflux effects of p-glycogprotein transporter.
Form
White solid
Intert gas (Yes/No)
Packaged under inert gas
CAS number
78755-81-4
Chemical formula
C₁₅H₁₄FN₃O₃
Structure formula
Purity
≥99% by HPLC
Solubility
DMSO (25 mM). Slight warming is required for complete solubilization.
Storage
Protect from light
+2°C to +8°C
Do Not Freeze
Ok to freeze
Special Instructions
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Toxicity
Standard Handling
References
Froklage, F.E., et al. 2012. EJNMMI Research.2, 12. Li, J., et al. 2006. Neuropharmacol.51, 168. Weiss, M., et al. 2002. Neurochem. Res.27, 1605. Atack, J., et al. 1999. Neuropsychopharmacol.20, 255. Votey, S.R., et al. 1991. Ann. Emerg. Med.20, 181.
